« Previous
Next »
Leukemia Research
Volume 34, Issue 2
, Pages 177-183
, February 2010
Flow cytometric detection of human telomerase reverse transcriptase (hTERT) expression in a subpopulation of bone marrow cells
References
- A highly conserved repetitive DNA sequence (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA. 1988;85:6622–6626
- . Structure and function of telomeres. Nature. 1991;350:569–573
- Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol. 1994;59:307–310
- . Telomere length and proliferation potential of hematopoietic stem cells. J Cell Sci. 1995;108:1–6
- Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol. 1995;155:3711–3715
- . Telomerase activity in normal leukocytes and in hematologic malignancies. Blood. 1995;85:2315–2320
- . Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA. 1995;92:9082–9086
- Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011–2015
- . Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA. 1994;91:9857–9860
- . Telomeres shorten during aging of human fibroblasts. Nature. 1990;345:458–460
- Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA. 1992;89:10114–10118
- Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet. 1992;52:661–667
- . Telomere reduction in human carcinoma and with aging. Nature. 1990;346:866–868
- . Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA. 1995;92:11190–11194
- Telomere shortening associated with chromosome instability in immortal cells which express telomerase activity. EMBO J. 1992;11:1921–1929
- Structure and variability of human chromosome ends. Mol Cell Biol. 1990;10:518–527
- . Clinical implications of telomerase in cancer. Eur J Cancer. 1997;33:781–786
- . A survey of telomerase activity in human cancer. Eur J Cancer. 1997;33:787–791
- . Clinical utility of telomerase in cancer. Oncogene. 2002;21:643–649
- Telomerase activity in gastric cancer. Cancer Res. 1995;55:3258–3262
- Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells. 1996;14:239–248
- Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents. Clin Cancer Res. 1996;2(5):799–803
- . Suppression of telomerase reverse transcriptase (hTERT) expression in differentiated HL-60 cells: regulatory mechanisms. Br J Cancer. 1999;80:1156–1161
- . Telomeres and telomerase in hematologic neoplasia. Oncogene. 2002;21:680–687
- . Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res. 1995;23:3794–3795
- . A nonradioactive, fluorescence-based telomeric repeat amplification protocol to detect and quantitate telomerase activity. Trends Genet. 1996;12(10):395–396
- The RNA component of human telomerase. Science. 1995;269:1236–1241
- hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell. 1997;22:785–795
- Telomerase catalytic subunit homologs from fission yeast and human. Science. 1997;277(5328):955–959
- . Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res. 1998;58(7):1558–1561
- . Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues. Neoplasia. 2001;3(1):17–26
- Significance of immunological detection of human telomerase reverse transcriptase. Re-evaluation of expression and localization of human telomerase reverse transcriptase. Am J Pathol. 2003;163:859–867
- . Immunohistochemical localization of hTERT protein in human tissues. Histochem Cell Biol. 2004;121:391–397
- . Telomerase activity in human germline and embryonic tissues and cells. Dev Genet. 1996;18(2):173–179
- . Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood. 1997;90:182–193
- . Telomeres and telomerase in normal and leukemic hematopoietic cells. Leukemia Res. 2004;28:1001–1004
- . Detection of hTERT protein by flow cytometry. Leukemia. 2000;14:2176–2181
- . Differentiation and proliferation of hematopoietic stem cells. Blood. 1993;81:2844–2853
- . Telomerase activity and the expression of telomerase components in acute myelogenous leukemia. Br J Haematol. 1998;102:1367–1375
- Clinical significance of telomerase activity in multiple myeloma. Cancer. 2002;4:2232–2238
PII: S0145-2126(09)00285-9
doi: 10.1016/j.leukres.2009.06.010
© 2009 Elsevier Ltd. All rights reserved.
« Previous
Next »
Leukemia Research
Volume 34, Issue 2
, Pages 177-183
, February 2010
